19-11173352-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The ENST00000586659.6(KANK2):c.2069-229A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.313 in 151,990 control chromosomes in the GnomAD database, including 7,782 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.31 ( 7782 hom., cov: 31)
Consequence
KANK2
ENST00000586659.6 intron
ENST00000586659.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0470
Genes affected
KANK2 (HGNC:29300): (KN motif and ankyrin repeat domains 2) This gene encodes a member of the KN motif and ankyrin repeat domains (KANK) family of proteins, which play a role in cytoskeletal formation by regulating actin polymerization. The encoded protein functions in the sequestration of steroid receptor coactivators and possibly other proteins. Mutations in this gene are associated with impaired kidney podocyte function and nephrotic syndrome, and keratoderma and woolly hair. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 19-11173352-T-C is Benign according to our data. Variant chr19-11173352-T-C is described in ClinVar as [Benign]. Clinvar id is 1295441.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.384 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KANK2 | NM_001136191.3 | c.2069-229A>G | intron_variant | ENST00000586659.6 | NP_001129663.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KANK2 | ENST00000586659.6 | c.2069-229A>G | intron_variant | 1 | NM_001136191.3 | ENSP00000465650 | P1 | |||
KANK2 | ENST00000588787.5 | c.267-229A>G | intron_variant | 5 | ENSP00000464896 | |||||
KANK2 | ENST00000589359.5 | c.2093-229A>G | intron_variant | 5 | ENSP00000468002 | |||||
KANK2 | ENST00000589894.1 | c.2069-229A>G | intron_variant | 5 | ENSP00000467029 |
Frequencies
GnomAD3 genomes AF: 0.313 AC: 47504AN: 151872Hom.: 7767 Cov.: 31
GnomAD3 genomes
AF:
AC:
47504
AN:
151872
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.313 AC: 47563AN: 151990Hom.: 7782 Cov.: 31 AF XY: 0.310 AC XY: 23064AN XY: 74300
GnomAD4 genome
AF:
AC:
47563
AN:
151990
Hom.:
Cov.:
31
AF XY:
AC XY:
23064
AN XY:
74300
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
858
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at